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Abstract
Background: The National Health Service (NHS) England spent £15.5 billion on medication in 2015. More than a third of
patients affected by at least one long-term condition do not adhere to their drug regime. Many interventions have been trialed to
improve medication adherence. One promising innovation is the electronic personal health record.
Objective: This systematic literature review aims to identify the important design features of personal health records to improve
medication adherence for patients with long-term conditions.
Methods: This protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P
2015) statement. The following databases will be searched for relevant articles: PubMed, Science Direct, BioMed Central,
Cumulative Index to Nursing and Allied Health Literature, Cochrane Database of Systematic Reviews, and the Cochrane Central
Register of Controlled Trials. Studies published in the last fifteen years, in English, will be included if the participants are adults
who were treated outside the hospital, have the ability to self-administer their medication, and have at least one long-term condition.
The review will exclude commercial or political sources and papers without references. Papers that research pediatrics, pregnant,
or terminally ill patients will also be excluded, since their medication management is typically more complex.
Results: One reviewer will screen the included studies, extract the relevant data, and assess the quality of evidence utilizing the
Grading of Recommendations Assessment, Development, and Evaluation system and the risk of bias using the Cochrane RevMan
tool. The second reviewer will assess the quality of 25% of the included studies to assess interrater agreement. Any disagreement
will be solved by a third reviewer. Only studies of high and moderate quality will be included for narrative synthesis.
Conclusions: NHS policy assumes that increasing usage of personal health records by citizens will reduce demand on health
care services. There is limited evidence, however, that the use of health apps can improve patient outcomes, and, to our knowledge,
this is the first systematic literature review aiming to identify important design features of the personal health record which may
improve medication adherence in the adult population with long-term conditions.
Trial Registration: PROSPERO CRD42017060542; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=60542
(Archived by WebCite at http://www.webcitation.org/6zeuWXxVh)
Registered Report Identifier: RR1-10.2196/9778
(JMIR Res Protoc 2018;7(6):e159)   doi:10.2196/resprot.9778
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Introduction
The annual National Health Service (NHS) England spend on
medication was £15.5 billion in 2015 and the volume of
medication prescribed in by NHS England rises every year [1-3].
The World Health Organization (WHO) reported that the
average medication adherence in patients with long-term
conditions in developed countries is approximately 50% [4].
According to the WHO, there is a need to acquire more data
related to medication adherence from all age band subgroups
[4]. It is estimated that, in the UK, more than a third of patients
with at least one long-term illness do not adhere to their
medication regime [5]. Medication nonadherence is associated
with higher number of hospitalizations, adverse drug reactions,
nursing home admissions, and an increase in health care and
social costs [6].
A number of systems are currently employed to use information
and communication technologies (ICT) to store, manage, and
employ health and medical information. The use of ICT for
NHS health care policy was made clear in the 2002 report,
Securing Our Future Health: Taking a Long-Term View [7],
even though patients’ electronic access to their health records
had already been planned in The NHS Plan 2000 [8]. Following
that, the NHS developed the Summary Care Record and
HealthSpace programs to explore the development and
application of shared electronic health records (EHRs) and
personal health records (PHRs) [9]. The NHS Future Forum
highlights the importance of patient access to their online GP
health records to assist in the development of a self-care and
self-management culture [10].
NHS policy documents and frameworks such as the Personalised
Health and Care 2020 (P2020) report [11] and the Five Year
Forward View [12] specify that the NHS needs to harness the
power of technology. The aim is to enable patients to make
correct choices and to support clinicians by providing access to
all necessary data and assisting the clinicians to make the most
of technology available and these data. The P2020 claims that
unless the gap between care and technology closes, patients
may experience “unnecessary levels of preventable ill health”
[11]. It also provides evidence of the growing demand for
technology in England, as evidenced by the fact that 59% of all
UK citizens have a smartphone. It also compares the health care
sector to other safety-critical industries and it argues that digital
tools and technologies, such as mobile apps, improve
self-management of patients’ health [11].
There are four main terms in general use for structured health
care information systems, namely electronic medical records
(EMRs), electronic patient records (EPRs), EHRs, and PHRs
[13]. Although there have been attempts to differentiate the
definitions of EMR, EPR, and EHR [14-16], in practice, these
terms lack precision and are often used interchangeably [13].
We have adopted the term “EHR” in this protocol. The definition
of a generic EHR is “a repository of information regarding the
health status of a subject of care, in computer processable form”
[13,17].
There are multiple definitions of a PHR. Generally, the term
“PHR” emerged from “EHR” and can be defined as “health
records related to patient care that are controlled by the patient”
[18]. Although there are paper based PHRs, in this protocol we
refer to PHRs that are electronic and accessible via mobile
devices [18].
Based on the PHR definitions provided by Cruickshank [9],
Paton [19], Rohers [18], and Archer [20], we identified the
common denominators and the following PHR definition is used
throughout this protocol and the systematic literature review:
PHRs are online systems that include collections of
patients’ health care and medical data, which utilize
health informatics standards to enable patients to
share, organize, and manage these data according to
their own views. [21]
This definition is agnostic to the type of PHR, which can be
defined as tethered [16,20,22] or standalone [18,20]. A tethered
(tied) PHR includes features that are not patient-controlled;
thus, it can be connected to the data source, including the cloud
and institutional EHRs [16,18,20]. Untethered or standalone
PHRs’ main feature is that the patient-user is the only one
permitted to enter, maintain, and self-manage data related to
their own health conditions [20,23]. Based on the above
definition, this review will also include studies that use copies
of personal health data on storage devices, such as smart cards
and USB sticks. Figure 1 illustrates how the EHR and PHR
differ for health care and medical records.
PHRs are typically important for patients that are suffering from
chronic conditions, whom gain the most value from the PHR
and have a higher adoption rate for PHR use [20,24-26]. Some
PHR characteristics, as derived by the literature [20,24-26], are
summarized in Table 1.
The adoption of PHRs is global, for example, PHRs are expected
to be adopted by 75% of patients in the USA by 2020 [27]. In
Australia, a national tethered PHR system has been launched
[28] and in Canada and Denmark there are health centers which
offer PHRs to their patients [9]. Furthermore, the NHS England
is working toward a greater adoption of PHRs [11,12,29]. There
is a growing focus on the adoption of PHRs worldwide because,
in addition to geographically targeting the major economies
such as the USA and UK, studies have also been conducted in
middle- and low-income countries to evaluate, improve, and
quantify the benefits of PHR use in global health [9,30-35].
The scope of this review is global and there are no geographical
restrictions on this study. The use of PHRs not only varies
between different groups of patients, but it also varies among
studies [36]. Patients that have a long-term condition or an
illness that requires recurrent care are more likely to use a PHR
than patients who claim to be in good health [37]. The adoption
of PHRs worldwide started around 2003 [9], so all the evidence
is recent, and this remains an immature and rapidly developing
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field. Illustrating this, early in 2011 Google decided to terminate
their PHR product (Google Health) due to its low impact and
adoption rate [9,38].
Figure 1. Description of the differences and concepts between electronic health records (EHRs) and personal health records (PHRs) [15,18]. GP: general
practitioner.
Table 1. Summary of personal health record (PHR) characteristics as derived by the literature [20,24-26].
ExamplesPHR Characteristic
Booking appointments, paying billsAdministrative
View lab test results, view prescriptions, add medical historyClinical features
May provide access to electronic health record dataOnline access
The patient’s data are controlled by patientManaged by patient
Organizing health information, documenting symptoms, documenting
medication dosages
Data repository
Between patients and/or patient-doctorImproves communications
Provides individualized and tailored clinical information to patientsPersonalization
Might be alarms or text messages etcMedication adherence reminders
NHS England engaged in a “landscape review” in 2015 to
identify how local NHS organizations and commercial
companies are using PHRs [39]. Most research and quality of
life and care schemes that the NHS is currently referencing have
been published after 2011 [11,36,40,41]. This context has
informed our selection of a suitable date range for the literature
searches.
There are many claimed benefits of PHRs, such as (1) the ability
of PHRs to improve patient outcomes, (2) decrease in care costs,
(3) to give patients the ability to self-manage their health, (4)
an increase access to care especially in remote areas, (5)
empowerment of patients, and (6) to improve medication
adherence [18-20,24-26,36,42,43].
Medication adherence can be defined as “the extent to which a
person’s behavior towards their medication intake, corresponds
with agreed recommendations from a health care provider” [44].
Medication adherence is the preferred terminology, but some
sources still use the word “compliance,” which many consider
to be dated as it is a more restrictive term and less patient
centered [45]. The ABC taxonomy [46] was selected as the
conceptual framework for medication adherence in this study
since it is well cited, it includes the time dimension, and it is
considered more comprehensive than the WHO five interacting
dimensions that affect adherence [44]. The ABC taxonomy
states that there are three components to medication adherence:
initiation (the time until the first dose has been taken),
implementation (the extent to which a patient’s dosage
consumption corresponds to the prescribed dose regimen) and
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discontinuation (stop taking the medication) [46]. Medication
adherence and persistence are closely related and often
persistence is incorporated in the notion of adherence [46,47].
Medication persistence can be defined as the extent to which
patients adhere over time [45], in other words it is the time
between the medication initiation until the medication
discontinuation [46]. According to some authors, medication
compliance and medication adherence are synonymous [46],
with the latter not only to be introduced as a less aggressive
term to describe the same phenomena but also to provide the
patient with a sense of self-control and self-management of their
treatment [48,49]. Concordance is another important term related
to adherence to prescribed medication, which reflects the need
to reach an agreement between a patient and the prescriber by
which health beliefs are accounted for. A concordant
consultation would be expected to lead to enhanced adherence
to medication, as the prescribing process would involve the
patient in the clinical decision making [48].
Some studies indicate that polypharmacy has a negative effect
on medication adherence [44,50,51]. Polypharmacy is defined
as the parallel use of multiple medications by one patient, for
complex or multiple conditions [52-54]. Polypharmacy can
signify “the prescribing of either many drugs (appropriately)”
or “too many drugs (inappropriately)” [55]. Our focus extends
to either use of polypharmacy, since the impact of PHRs on
either polypharmacy or simple prescribing is unknown.
Medication adherence is a well-known challenge in health care
[44,56-58], and is related to a large number of factors such as
side effects [59], forgetfulness [57], or effective
self-management and is affected by psychological factors and
beliefs [60]. Although a number of strategies and interventions
have been identified to assist patients’ medication adherence
[58,61], they have had limited success.
NHS policy assumes that increasing the usage of health apps
by citizens will reduce demand on health care services.
However, the quality of the literature about the use of health
apps to improve patient outcomes is often questionable [62].
Aim and Objectives
The aim of this systematic review is to identify important design
features of the electronic PHR that may improve medication
adherence in the adult population with long-term conditions.
Primary Objective
The primary objective of this systematic review is to identify
the important design features of the electronic PHR which may
improve medication adherence in the adult population with
long-term conditions.
Secondary Objectives
• Identify the PHR design features that improve medication
adherence in the cases of:
• Polypharmacy;
• Specific long-term condition groups;
• Identify if there is a correlation between participants’
demographic characteristics, their usage of PHRs, and their
medication adherence;
• Explore how implementation factors affect the outcomes.
Methods
This protocol complies with the requirement of the Preferred
Reporting Items for Systematic Reviews and Meta-analyses
Protocol (PRISMA-P 2015) including the PICOS elements
(participants, interventions, comparators, outcomes and study
design) highlighted in Table 2 [63].
Table 2. Summary of the PICOS elements (participants, interventions, comparators, outcomes and study design) included and excluded in the systematic
review.
Exclusion criteriaInclusion criteriaVariable
Participants •• AnimalsHumans
• •Adults with at least one long-term condition Pregnant, cancer, or terminally ill patients
•• Adults with medically serious problems that are not classified
as long-term conditions
Patients that can self-administer their medication
• Patients that are able to communicate freely and able to self-
manage their medication • Patients that require assistance with taking their medication
• •Patients treated outside the hospital only Patients unable to communicate or unable to self-manage their
medication.
• Inpatients or patients living in care homes
N/AbInterventions of any type, intensity and frequency, that aim to in-
vestigate the effect of electronic PHRsa in medication adherence,
concordance, compliance or persistence.
Intervention
N/AN/AComparators
N/AAny outcome related to the effect of electronic PHRs in medication
adherence, concordance, compliance or persistence
Outcome
Abstract-only reports without any references, commercial studies,
party political statements, general discussion papers, magazine or
newspaper articles, withdrawn abstracts or articles, protocols of
reviews
Studies or literature reviews published in the last fifteen years,
without any geographical restriction
Study design
or type
aPHR: personal health record.
bN/A: not applicable.
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Search and Selection Strategy
High heterogeneity of the data is expected, in terms of target
diseases, interventions, outcome measures, and study types.
Therefore, a meta-analysis is avoided in favor of a qualitative
analysis. A narrative synthesis [64] of the peer-reviewed medical
and nursing literature as indexed in PubMed/MEDLINE,
PubMed Central, Association for Computing Machinery digital
library, Emerald Insight, Science Direct, BioMed Central, and
Cumulative Index to Nursing and Allied Health Literature will
be undertaken. The Cochrane Database of Systematic Reviews
and the Cochrane Central Register of Controlled Trials will also
be searched and any abstract-only reports without any citations
will be excluded. Additional papers derived manually from the
reference lists of the selected articles or studies, as well as from
Research Gate and Google Scholar during the screening process,
will also be included. Conference proceedings will also be
searched using the Web of Science and IEEE Xplore databases.
Discovery services from ProQuest will be used to include theses
and dissertations on the search. All published studies, as
described above, reported during the past fifteen years will be
considered. Two reviewers (EA, PJS) will screen the included
studies.
Papers in English will be considered for this review. The studies
selection will be managed using Mendeley Desktop v 1.17.9
and Mendeley Web.
The search strategy was developed iteratively, based on trial
searches, using the PICOS framework [63], together with a
university librarian, and takes into consideration the methods
section of previous systematic literature reviews in the field.
The search strategy used is:
(phr OR “personal health record” OR “patient
portal”) AND adult* AND (“chronic disease” OR
“chronic illness” OR “chronic condition” OR “long
term disease” OR “long term illness” OR “long term
condition”) AND [“medication compliance” OR
“medication adherence” OR “medication
concordance” OR “medication persistence”]
The search includes the following MeSH [65] terms: personal
health records, medication adherence, and chronic disease.
The strategy does not include the terms “p.h.r.” nor “P.H.R.,”
since these terms obscured the preliminary results by adding an
unnecessary load of marketing and human resources related
results, which are clearly out of the scope of this research. The
search terms of the strategy were combined with Boolean
Operators (ie, “AND” and “OR”). During preliminary searches,
the word PHR was replaced by the words “medication record”
or “medication profile” based on pharmacist advice; this search
yielded very similar results in PubMed Central and, in fact,
excluded 2 studies. A search that initially seemed promising
was including the word “medication” and the word “adherence”
by themselves (ie, “medication” AND “adherence”). A similar
preliminary search excluded the word medication altogether.
These two searches yielded tens of thousands of hits, which
initially seemed promising, but, upon inspection, it was apparent
that either the papers were investigating PHRs as recreational
software, commonly for depression and weight loss, or the
papers were investigating PHRs in conjunction with adherence
to general therapeutically regimens such as weight loss and gym
attendance.
Participants
As illustrated in Table 1, the inclusion and exclusion criteria
for the participants are the following. Studies that include adult
patients with any long-term disease and use any type of
self-administering medication will be assessed for inclusion.
For this review, adult is defined as  18 years of age.
Studies that include adult patients with cancer, who are
terminally ill, pregnant, or have any other problems which make
patients unable to communicate freely and self-manage their
medication will be excluded. Studies that include only inpatients
or care home residents will be excluded.
Intervention
Interventions researching influences which affect patient
medication adherence will be included in this review as
described in Table 1. Included studies will include interventions
of any type, intensity, and frequency, which aim to investigate
the effect of PHRs on medication adherence, compliance,
persistence, and concordance.
The interventions may initially be grouped as:
• Interventions that explore the effect of PHR on medication
adherence [44,46,66], compliance [45,46], persistence [66],
and concordance [45];
• Interventions that explore how and how much patients use
PHRs and the effect this use might have in medication
adherence, compliance, persistence and perceptions;
• Interventions that explore the notion of polypharmacy in
adult patients with multiple conditions and how PHRs and
technology in general may be of assistance.
Outcome
The primary outcome of the studies included in the review is
medication adherence. However, medication adherence,
compliance, persistence, and/or concordance are complicated
terms to measure and often depend on the authors’ point of
view, background, and the authors’ definitions of the above
terms [48]. Furthermore, there is often a confusion surrounding
the differences between the terms, for example, the difference
between medication adherence and persistence [56]. Due to this
complexity, an inclusive approach will be used to determine
the outcomes of the included studies.
Data Extraction
The data extraction forms were created based on the National
Institute for Health and Care Excellence data extraction forms
[67] and the data extraction chapter from the Cochrane
Collaboration [68]. In cases of missing data on the PICOS
elements, an email will be sent to the authors of the study. If
there is no response within two weeks, a second email will be
sent, and if there is still no response from the authors, the study
will be excluded. The data extraction forms were designed to
collect all the data needed to address the review questions and
to follow the data synthesis strategy. The forms were piloted
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on a random selection of 10 of the included studies to assess
any potential issues (Multimedia Appendix 1).
The following information will be extracted from each study:
1. Basic study characteristics (eg, title, authors, journal,
abstract, keywords, publication, aim)
2. Study design and study period
3. Population characteristics (eg, age, number of participants,
chronic illness etc)
4. Intervention characteristics (eg, length of use, design
features, technological characteristics, vendor of PHR, type
of PHR)
5. Outcome measures (eg, self-reported, clinical outcomes,
medication adherence ideal)
6. Outcomes (eg, primary and secondary outcomes involving
medication adherence, quality of life, and polypharmacy)
Besides the above data, additional information will be
documented for the quality assessment and risk of bias analysis,
as described below.
Quality Assessment and Risk of Bias
Each eligible study will be assessed for validity and quality of
evidence, using the Critical Appraisal Tools written by The
Joanna Briggs Institute [69]. If there are studies that are eligible
for inclusion, but have missing data, the authors of these studies
will be contacted to see if these data can be obtained and used
in this review.
Each eligible study will also be assessed for risk of bias using
the Cochrane handbook 2011 [70]. The Grading of
Recommendations Assessment, Development, and Evaluation
(GRADE) tool [71] will be used to assess the quality of the
aggregate evidence for each outcome, based upon five factors:
risk of bias, inconsistency, indirectness, imprecision, and
publication bias. The quality of evidence will be rated as high,
moderate, low, or very low for every outcome.
The main reviewer (EA) will evaluate all the included studies,
the second reviewer (PJS) will evaluate 25% of the included
studies and interrater reliability will be calculated [72]. Any
disagreement will be solved by consulting a third reviewer.
Only studies of high and moderate quality, as defined by
GRADE [73], will be included in the review.
Data Synthesis and Analysis
Based on the aim of this review, the wide range coverage of
research designs, multiple interventions and outcomes, as well
as the expectation of high heterogeneity, all the data that will
be extracted from the studies will be analyzed narratively using
an interpretative framework [64,74]. To ensure that the narrative
analysis will be of good quality, the “Guidance on the Conduct
of Narrative Synthesis in Systematic Reviews” [64] will be
followed, which is in line with the Cochrane data synthesis and
analysis guidelines [74].
The narrative analysis will attempt an investigation into the
similarities and the differences between the outcomes of
different studies and an exploration of themes (patterns) in the
data. The guidelines [64,74], include the following four stages
of a narrative synthesis in reviews:
1. Development of a theory of how the intervention works,
why, and for whom. The initial theory and the
familiarization with the data will be achieved based on the
development of a textual description of the studies, which
will be produced systematically including, where possible,
the same information for all studies and in the same order
[64].
2. Development of a preliminary synthesis of the findings of
the included studies. The preliminary synthesis will be
developed using a tabular analysis of the studies in multiple
tables, using Microsoft Excel, followed by a thematic
analysis, which will systematically identify the recurrent
themes across the included studies [64].
3. Exploration of the relationships in the data between and
within studies. A conceptual model will be developed to
explore relationships in the data, which will group similar
findings and identify relationships between these groups,
providing visualization of the possible relationships across
studies [64].
4. Assessment of the robustness of the synthesis. A Best
Evidence Synthesis (BES) approach will be followed BES
is typically applied during the selection process and is
primarily concerned with the methodological quality of the
included studies. BES guidelines require that all the
included studies will meet the minimum standards for
relevance and quality of evidence, and that all the extracted
data will be systematically extracted based on the data
extraction forms. Therefore, the decision regarding the
“strength of evidence” will be made early in the review
process [64].
The analysis will be conducted in an iterative and abductive
way and the results will be thoroughly discussed with the other
two authors (PJS and HH).
Potential Amendments
There is no intention to amend the protocol; thus, the possibility
of outcome reporting bias will be reduced. However, if any
amendments are needed during the review process, they will be
clearly and comprehensively reported.
Results
There is no requirement for ethical review since this study is
secondary research. The final report of the systematic review
in the form of a scientific paper will be published in a
peer-reviewed journal. Findings may further be presented at
conferences and be submitted to relevant NHS authorities. We
also plan to include an updated version of this systematic review
in the author’s thesis.
Discussion
This research is limited to include only articles that have
outcomes related to the effect of electronic PHRs in medication
adherence, concordance, compliance, or persistence, rather than
also including other outcomes such as quality of life. In this
sense, the review will focus exclusively on articles that measure
medication adherence as a primary or secondary outcome. This
review is limited to obtain articles published either in ICT or
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health care and medical portals. This means that a lot of ICT
related literature is unobtainable, since it in not included in the
academic literature, but is commercial or governmental work.
The aim of this review is to identify the essential design features
of the PHR that assist adults with at least one long-term
condition to adhere with their medication, without taking into
consideration adolescents nor adults that are not considered
chronically ill or terminally ill, have cancer, or are pregnant.
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